Express antibodies with enhanced antibody-dependent cellular cytotoxicity (ADCC) with proven POTELLIGENT®CHOK1SV®technology

Get support in the production of antibodies with enhanced antibody-dependent cellular cytotoxicity (ADCC), helping you to improve the efficacy of your cytotoxic therapeutic candidates. The  POTELLIGENT® CHOK1SV® host cell line and recombinant cell lines derived from POTELLIGENT® CHOK1SV® exhibit good growth characteristics.

Antibodies produced by this cell line:

  • Can exert potent cytotoxic effects even when their target antigen density is low
  • Retain all the other desirable features of antibodies such as Protein A binding

Take advantage of our established CHOK1SV® cell line lineage

In the growing field of therapeutic antibodies, drug developers are continually searching for new strategies to improve efficacy. Optimization of antibody molecules by Fc engineering is a major opportunity here. Potency can be increased by enhancing antibody-dependent cellular cytotoxicity (ADCC) – 100% fucose-free antibodies in glycan moieties show much higher ADCC activity than normally fucosylated antibodies.

Through our partnership with BioWa, we can help you take advantage of this strategy. By fully removing fucose content, BioWa’s POTELLIGENT® Technology can increase the potency and efficacy of your antibody drugs. The POTELLIGENT® CHOK1SV® cell line technology enables the rapid expression of highly productive and stable recombinant cell lines.

Access to industry-leading technologies

The POTELLIGENT® CHOK1SV® cell line is available under a license. Contact us to find out more.

For latest research using POTELLIGENT® technology

Related content

Meet the Experts
Learn more from each of our subject matter experts about recent innovative projects and industry trends.
To learn more about GS piggyBac®
GS Xceed® Expression System toolbox now also includes GS piggyBac® - a unique and versatile cell line engineering technology. Learn more here.
To learn more about GS System®
Our GS Xceed® Expression System is a robust, fully integrated, scalable mammalian expression platform for producing recombinant therapeutic proteins. Our extensive technical...
To learn more about XS Technologies®
With over 30 years of experience in microbial expression, we can help you optimize the production of biotherapeutics. Our versatile XS Technologies® offer an extensive microbial...
Knowledge Center
Gather additional industry and technical information from our repository of resources and educational content.